Identification of Target Genes for Diagnosis and Prognosis of AML Using a Custom-Design Microarray
OBJECTIVES:
- To identify and validate individual genes for diagnosis of three major translocations
in acute myeloid leukemia.
- To correlate transcript expression data in the various translocations with age, sex,
race, response to treatment, and survival and with other known mutations.
OUTLINE: Blood and/or bone marrow samples previously procured from patients on CALGB-9665
are obtained from the CALGB Leukemia Tissue Bank from patients enrolled on CALGB AML
treatment studies. Mononuclear cells are isolated from samples and mRNA is extracted. Gene
expression profiles are analyzed via custom mRNA microarray and confirmed by quantitative
real-time PCR.
Observational
N/A
Correlation of increased or decreased expression of same transcripts with disease outcome
No
Janet Rowley, MD
Study Chair
University of Chicago
Unspecified
CDR0000595708
NCT00897182
May 2008
Name | Location |
---|---|
Wayne Memorial Hospital, Incorporated | Goldsboro, North Carolina 27534 |
Fort Wayne Medical Oncology and Hematology | Fort Wayne, Indiana 46815 |